Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Total Non-Current Liabilities (2022 - 2025)

Historic Total Non-Current Liabilities for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $32.3 million.

  • Prokidney's Total Non-Current Liabilities rose 574.41% to $32.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.3 million, marking a year-over-year increase of 574.41%. This contributed to the annual value of $38.7 million for FY2024, which is 3504.61% up from last year.
  • Prokidney's Total Non-Current Liabilities amounted to $32.3 million in Q3 2025, which was up 574.41% from $31.8 million recorded in Q2 2025.
  • Prokidney's 5-year Total Non-Current Liabilities high stood at $38.7 million for Q4 2024, and its period low was $11.6 million during Q3 2022.
  • Over the past 4 years, Prokidney's median Total Non-Current Liabilities value was $26.8 million (recorded in 2023), while the average stood at $25.8 million.
  • Per our database at Business Quant, Prokidney's Total Non-Current Liabilities surged by 12418.03% in 2023 and then plummeted by 206.85% in 2024.
  • Prokidney's Total Non-Current Liabilities (Quarter) stood at $12.8 million in 2022, then surged by 124.18% to $28.6 million in 2023, then surged by 35.05% to $38.7 million in 2024, then decreased by 16.49% to $32.3 million in 2025.
  • Its last three reported values are $32.3 million in Q3 2025, $31.8 million for Q2 2025, and $35.3 million during Q1 2025.